Pemvidutide
Also known as: ALT-801
A dual GLP-1/glucagon agonist built specifically to target and eliminate liver fat while driving 15%+ systemic weight loss.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~6–7 days
Titrated weekly
Subcutaneous injection
Mechanism of Action
Leverages glucagon receptor activation to mobilize hepatic lipids while GLP-1 suppresses appetite, uniquely resolving MASH/NAFLD.
Key Research Areas
Frequently Asked Questions
What is Pemvidutide?▾
How does Pemvidutide work?▾
What is the recommended dosage for Pemvidutide?▾
What is the half-life of Pemvidutide?▾
Is Pemvidutide FDA approved?▾
Ready to get started with Pemvidutide?
Order from our COA-verified partner — free US shipping, pharmaceutical-grade quality.
Research Disclaimer
The information provided about Pemvidutide is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.